Summit Securities Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-19
| Closed | -$13.5K | – | 901 |
|
|
2024
Q4 | $13.5K | Buy |
+19
| New | +$13.5K | ﹤0.01% | 294 |
|
|
2024
Q3 | – | Sell |
-14
| Closed | -$15K | – | 691 |
|
|
2024
Q2 | $15K | Buy |
+14
| New | +$15K | ﹤0.01% | 295 |
|
|
2024
Q1 | – | Sell |
-9
| Closed | -$8K | – | 637 |
|
|
2023
Q4 | $8K | Sell |
9
-3
| -25% | -$2.67K | ﹤0.01% | 337 |
|
|
2023
Q3 | $10K | Sell |
12
-23
| -66% | -$19.2K | ﹤0.01% | 271 |
|
|
2023
Q2 | $25K | Buy |
+35
| New | +$25K | ﹤0.01% | 454 |
|
|
2022
Q4 | – | Sell |
-421
| Closed | -$290K | – | 1080 |
|
|
2022
Q3 | $290K | Buy |
+421
| New | +$290K | 0.02% | 217 |
|
|
2022
Q2 | – | Sell |
-481
| Closed | -$336K | – | 906 |
|
|
2022
Q1 | $336K | Buy |
+481
| New | +$336K | 0.04% | 171 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 234 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 276 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 199 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 199 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 170 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 152 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 158 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 192 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 202 |
|